Gentamicin‐Linked Supramolecular Hybrid Hydrogels: Mechanically Robust Cucurbit[7]Uril‐Based Networks for Prolonged Infection Control
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71477 ↗At a glance
Journal article in Advanced Healthcare Materials, 2026. Written by A Aslihan Gokaltun and 6 co-authors. Institution: Center For Engineering in Medicine and Surgery, Massachusetts General Hospital, Department of Surgery, Harvard Medical School, Boston, Massachusetts,…. Major MEDLINE topics: Hydrogels, Gentamicins, Imidazoles, Bridged-Ring Compounds. 57 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, NIAMS NIH HHS, NHLBI NIH HHS.
Topics: Nosokomiale Infektionen
Abstract (original language)
Burn wound infections, caused by Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) , remain a major clinical challenge, delaying healing and increasing the risk of mortality. Gentamicin sulfate (GEN) is a broad‐spectrum antibiotic widely used for infection control. However, conventional GEN‐loaded hydrogels often suffer from burst release and inadequate mechanical strength for sustained wound coverage. Here, we report GEN‐loaded (0.11–0.72 w/v%) supramolecular hybrid hydrogels (GEN‐SHHs) in which GEN acts in a dual role as both an antimicrobial and a dynamic physical crosslinker through cucurbit[7]uril (CB[7]) host–guest interactions within a clay‐reinforced hydrogel network. This polymer network gels within 5 s and achieves an exceptional elastic modulus (up to ∼270 kPa), the highest reported for CB[7]‐based or antibiotic‐crosslinked hydrogels. This integrated design achieves sustained GEN release for 14 days at concentrations above the minimum inhibitory and bactericidal thresholds for S. aureus and P. aeruginosa , yielding complete eradication (>99.999%) at GEN loadings ≥0.44 w/v%. Prolonged antimicrobial efficacy is further confirmed by persistent inhibition zones over two weeks. GEN‐SHHs also maintain high cytocompatibility (>94% viability) with human dermal fibroblasts (HDFs) and epidermal keratinocytes (HEKs). These results establish GEN‑SHHs combining dynamic bonding, high stiffness, and durable antimicrobial performance for advanced infection‐resistant wound dressings.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center For Engineering in Medicine and Surgery, Massachusetts General Hospital, Department of Surgery, Harvard Medical School, Boston, Massachusetts, USA.
- Shriners Children's Boston, Boston, Massachusetts, USA.
- Department of Chemical and Biological Engineering, Tufts University, Medford, Massachusetts, USA.
- Wellman Center for Photomedicine, Massachusetts General Hospital, Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA.
ORCID profiles: A Aslihan Gokaltun, Ayse Asatekin
Funding
- NIGMS NIH HHS
- NIAMS NIH HHS
- NHLBI NIH HHS
- NIH HHS
- National Science Foundation
- Massachusetts General Hospital (MGH) Executive Committee on Research (ECOR)
- Shriners Hospital Howard Green Research Grant
- National Institutes of Health
Cite
APA
Gokaltun, A. A., Shrestha, D., Dos Anjos, C., Khoshnevisan, N., Dai, T., Asatekin, A., & Usta, O. B. (2026). Gentamicin‐Linked Supramolecular Hybrid Hydrogels: Mechanically Robust Cucurbit[7]Uril‐Based Networks for Prolonged Infection Control. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71477
Vancouver
Gokaltun AA, Shrestha D, Dos Anjos C, Khoshnevisan N, Dai T, Asatekin A, et al. Gentamicin‐Linked Supramolecular Hybrid Hydrogels: Mechanically Robust Cucurbit[7]Uril‐Based Networks for Prolonged Infection Control. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71477
BibTeX
@article{Gokaltun2026,
author = {Gokaltun, A Aslihan and Shrestha, Dinesh and Dos Anjos, Carolina and Khoshnevisan, Nafiseh and Dai, Tianhong and Asatekin, Ayse and Usta, O Berk},
title = {Gentamicin‐Linked Supramolecular Hybrid Hydrogels: Mechanically Robust Cucurbit[7]Uril‐Based Networks for Prolonged Infection Control},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71477}
}
EUVIMED